|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00254755
|
|
|
RDPA
|
[NCBI]
|
0.00160726
|
|
|
iminoglycinuria
|
[NCBI]
|
0.00141508
|
|
|
SLE
|
[NCBI]
|
0.00134435
|
|
|
LI5
|
[NCBI]
|
0.00124481
|
|
|
EFMR
|
[NCBI]
|
0.000972075
|
|
|
UFS
|
[NCBI]
|
0.000888078
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
0.000820387
|
|
|
MRT5
|
[NCBI]
|
0.000802798
|
|
|
RP22
|
[NCBI]
|
0.000802798
|
|
|
MRT10
|
[NCBI]
|
0.000802798
|
|
|
DFNB35
|
[NCBI]
|
0.000802798
|
|
|
DFNB63
|
[NCBI]
|
0.000802798
|
|
|
DFNB17
|
[NCBI]
|
0.000802798
|
|
|
MCPH2
|
[NCBI]
|
0.000802798
|
|
|
SLSN3
|
[NCBI]
|
0.000802798
|
|
|
MSSD
|
[NCBI]
|
0.000802798
|
|
|
MRT8
|
[NCBI]
|
0.000802798
|
|
|
DFNB27
|
[NCBI]
|
0.000802798
|
|
|
salivary substance, clostridium botulinum type
|
[NCBI]
|
0.000802798
|
|
|
MRT11
|
[NCBI]
|
0.000802798
|
|
|
muscular dystrophy, congenital, 1b
|
[NCBI]
|
0.000802798
|
|
|
MRT9
|
[NCBI]
|
0.000802798
|
|
|
RP25
|
[NCBI]
|
0.000802798
|
|
|
camptobrachydactyly
|
[NCBI]
|
0.000802798
|
|
|
MRT7
|
[NCBI]
|
0.000802798
|
|
|
DFNB39
|
[NCBI]
|
0.000802798
|
|
|
xanthomatosis, susceptibility to
|
[NCBI]
|
0.000802798
|
|
|
deafness, congenital neurosensory, autosomal recessive 38
|
[NCBI]
|
0.000802798
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.000737717
|
|
|
AMCN
|
[NCBI]
|
0.000672847
|
|
|
microcephalic osteodysplastic primordial dwarfism, type i
|
[NCBI]
|
0.000672847
|
|
|
MYP2
|
[NCBI]
|
0.000543202
|
|
|
stomatocytosis ii
|
[NCBI]
|
0.00054047
|
|
|
MRT12
|
[NCBI]
|
0.00054047
|
|
|
PDB4
|
[NCBI]
|
0.00054047
|
|
|
NNCI
|
[NCBI]
|
0.00054047
|
|
|
saccharopinuria
|
[NCBI]
|
0.00054047
|
|
|
DFNB13
|
[NCBI]
|
0.00054047
|
|
|
SCAR5
|
[NCBI]
|
0.00054047
|
|
|
myasthenia, familial infantile, 1
|
[NCBI]
|
0.00054047
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.00054047
|
|
|
SCAR3
|
[NCBI]
|
0.00054047
|
|
|
diarrhea 3, secretory sodium, congenital
|
[NCBI]
|
0.00054047
|
|
|
EGF
|
[NCBI]
|
0.000498866
|
|
|
IGAD1
|
[NCBI]
|
0.000494091
|
|
|
USH1E
|
[NCBI]
|
0.000443255
|
|
|
MHAC
|
[NCBI]
|
0.000443255
|
|
|
thyroid hormonogenesis, genetic defect in, 4
|
[NCBI]
|
0.000443255
|
|
|
CHDS8
|
[NCBI]
|
0.000443255
|
|
|
DFNB5
|
[NCBI]
|
0.000443255
|
|
|
b-cell malignancy, low-grade
|
[NCBI]
|
0.000443255
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.000443255
|
|
|
pentosuria
|
[NCBI]
|
0.000443255
|
|
|
bruck syndrome 1
|
[NCBI]
|
0.000443255
|
|
|
anodontia of permanent dentition
|
[NCBI]
|
0.000443255
|
|
|
SCAR6
|
[NCBI]
|
0.000443255
|
|
|
CRC
|
[NCBI]
|
0.000435606
|
|
|
HFE
|
[NCBI]
|
0.000430475
|
|
|
MDD
|
[NCBI]
|
0.000423904
|
|
|
JBTS1
|
[NCBI]
|
0.000415014
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000381137
|
|
|
MYP3
|
[NCBI]
|
0.000381137
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.000381137
|
|
|
VDEGS
|
[NCBI]
|
0.000381137
|
|
|
CMT2B2
|
[NCBI]
|
0.000381137
|
|
|
noonan syndrome 2
|
[NCBI]
|
0.000381137
|
|
|
VEGF
|
[NCBI]
|
0.000370443
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
0.000339917
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
0.000335688
|
|
|
NAD
|
[NCBI]
|
0.000335688
|
|
|
cerebellar ataxia and hypogonadotropic hypogonadism
|
[NCBI]
|
0.000335688
|
|
|
chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism
|
[NCBI]
|
0.000335688
|
|
|
USH2B
|
[NCBI]
|
0.000335688
|
|
|
IBD3
|
[NCBI]
|
0.000335688
|
|
|
HBFQTL2
|
[NCBI]
|
0.000327161
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.000327161
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000303446
|
|
|
CCA1
|
[NCBI]
|
0.000300057
|
|
|
MKS2
|
[NCBI]
|
0.000300057
|
|
|
RNANC
|
[NCBI]
|
0.000300057
|
|
|
STHAG4
|
[NCBI]
|
0.000300057
|
|
|
dysgnathia complex
|
[NCBI]
|
0.000300057
|
|
|
CNC2
|
[NCBI]
|
0.000300057
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
0.000282197
|
|
|
TNF
|
[NCBI]
|
0.000276579
|
|
|
SPS
|
[NCBI]
|
0.000271737
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
0.000270913
|
|
|
DBQD
|
[NCBI]
|
0.000270913
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.000270913
|
|
|
BMND3
|
[NCBI]
|
0.000270913
|
|
|
gonadal dysgenesis, xx type, with deafness
|
[NCBI]
|
0.000270913
|
|
|
AD
|
[NCBI]
|
0.000265869
|
|
|
FMF
|
[NCBI]
|
0.000257407
|
|
|
MG
|
[NCBI]
|
0.000250839
|
|
|
MTHFR
|
[NCBI]
|
0.000247428
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.00024638
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.00024638
|
|
|
BBS
|
[NCBI]
|
0.000244142
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
0.000231599
|
|
|
NGFB
|
[NCBI]
|
0.000230024
|
|
|
IBD2
|
[NCBI]
|
0.000225295
|
|
|
ADFN
|
[NCBI]
|
0.000225295
|
|
|
LDLR
|
[NCBI]
|
0.000224805
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
0.000219062
|
|
|
CF
|
[NCBI]
|
0.000214125
|
|
|
SHFM1
|
[NCBI]
|
0.0002116
|
|
|
factor v deficiency
|
[NCBI]
|
0.000210557
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000206886
|
|
|
TOC
|
[NCBI]
|
0.000206886
|
|
|
PEE1
|
[NCBI]
|
0.000204271
|
|
|
NPHP2
|
[NCBI]
|
0.000204143
|
|
|
APRT
|
[NCBI]
|
0.000203514
|
|
|
NPY
|
[NCBI]
|
0.000196274
|
|
|
PI
|
[NCBI]
|
0.00019555
|
|
|
KLK3
|
[NCBI]
|
0.000194405
|
|
|
PRL
|
[NCBI]
|
0.000194357
|
|
|
ACG1A
|
[NCBI]
|
0.000190615
|
|
|
PTH
|
[NCBI]
|
0.000189495
|
|
|
PCNA
|
[NCBI]
|
0.000187216
|
|
|
APC
|
[NCBI]
|
0.000186465
|
|
|
AT
|
[NCBI]
|
0.000185417
|
|
|
HBB
|
[NCBI]
|
0.000185377
|
|
|
EAOH
|
[NCBI]
|
0.000184236
|
|
|
HHC1
|
[NCBI]
|
0.000179431
|
|
|
SLSN1
|
[NCBI]
|
0.000171994
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000171614
|
|
|
porphyria variegata
|
[NCBI]
|
0.00017155
|
|
|
WRN
|
[NCBI]
|
0.000170821
|
|
|
WFS2
|
[NCBI]
|
0.000156785
|
|
|
ARH
|
[NCBI]
|
0.000156496
|
|
|
ACADM
|
[NCBI]
|
0.000155476
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
0.000153943
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000151361
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000151187
|
|
|
CCK
|
[NCBI]
|
0.000150231
|
|
|
LGMD2I
|
[NCBI]
|
0.000149855
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
0.000149855
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
0.000149855
|
|
|
NPC1
|
[NCBI]
|
0.000148312
|
|
|
EGFR
|
[NCBI]
|
0.000145978
|
|
|
PWS
|
[NCBI]
|
0.000145684
|
|
|
SMA1
|
[NCBI]
|
0.00014433
|
|
|
gilbert syndrome
|
[NCBI]
|
0.000143788
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000143269
|
|
|
CEACAM5
|
[NCBI]
|
0.000142172
|
|
|
F5F8D
|
[NCBI]
|
0.00014104
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000141013
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000140404
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000140404
|
|
|
LI1
|
[NCBI]
|
0.000137291
|
|
|
CFTR
|
[NCBI]
|
0.000137197
|
|
|
VIP
|
[NCBI]
|
0.000135796
|
|
|
ABL
|
[NCBI]
|
0.00013472
|
|
|
gaucher disease, type i
|
[NCBI]
|
0.000133236
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
0.000133048
|
|
|
hydatidiform mole
|
[NCBI]
|
0.000133048
|
|
|
AMDM
|
[NCBI]
|
0.000131184
|
|
|
PRNP
|
[NCBI]
|
0.00012952
|
|
|
ACHE
|
[NCBI]
|
0.000128417
|
|
|
GJB2
|
[NCBI]
|
0.000127518
|
|
|
cystinuria
|
[NCBI]
|
0.0001251
|
|
|
CRH
|
[NCBI]
|
0.000123816
|
|
|
complement component 2 deficiency
|
[NCBI]
|
0.000123671
|
|
|
polycystic kidneys
|
[NCBI]
|
0.000123446
|
|
|
MRT3
|
[NCBI]
|
0.000118932
|
|
|
LCA4
|
[NCBI]
|
0.000118932
|
|
|
hypotonia-cystinuria syndrome
|
[NCBI]
|
0.000118932
|
|
|
MCPH5
|
[NCBI]
|
0.00011564
|
|
|
CMT4C
|
[NCBI]
|
0.00011564
|
|
|
APL
|
[NCBI]
|
0.000115628
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
0.000115628
|
|
|
SHFM3
|
[NCBI]
|
0.0001131
|
|
|
IGAN1
|
[NCBI]
|
0.0001131
|
|
|
CDAN2
|
[NCBI]
|
0.0001131
|
|
|
ARSA
|
[NCBI]
|
0.000112637
|
|
|
PHA1
|
[NCBI]
|
0.000109296
|
|
|
TGD
|
[NCBI]
|
0.000108388
|
|
|
HGF
|
[NCBI]
|
0.000108331
|
|
|
AFP
|
[NCBI]
|
0.000105261
|
|
|
BLM
|
[NCBI]
|
0.000104279
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
0.000103639
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
0.000103639
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
0.000103639
|
|
|
acheiropody
|
[NCBI]
|
0.000103639
|
|
|
HHF4
|
[NCBI]
|
0.000102045
|
|
|
LI3
|
[NCBI]
|
0.000102045
|
|
|
CLN7
|
[NCBI]
|
0.000102045
|
|
|
APOE
|
[NCBI]
|
0.000101757
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
9.98136e-05
|
|
|
SMN1
|
[NCBI]
|
9.97525e-05
|
|
|
HPS
|
[NCBI]
|
9.92597e-05
|
|
|
LCA1
|
[NCBI]
|
9.88698e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
9.85403e-05
|
|
|
small cell cancer of the lung
|
[NCBI]
|
9.81835e-05
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
9.81835e-05
|
|
|
GFAP
|
[NCBI]
|
9.70702e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
9.59948e-05
|
|
|
ACHM2
|
[NCBI]
|
9.39062e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
9.39062e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
9.34156e-05
|
|
|
ACH
|
[NCBI]
|
9.30513e-05
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
9.15103e-05
|
|
|
FTD
|
[NCBI]
|
9.10238e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
9.05795e-05
|
|
|
STL3
|
[NCBI]
|
9.05795e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
8.96637e-05
|
|
|
GAN1
|
[NCBI]
|
8.96637e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
8.96637e-05
|
|
|
UGT1A1
|
[NCBI]
|
8.96506e-05
|
|
|
BIRC1
|
[NCBI]
|
8.88501e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
8.81066e-05
|
|
|
phenylketonuria
|
[NCBI]
|
8.8015e-05
|
|
|
GBA
|
[NCBI]
|
8.64386e-05
|
|
|
PFIC1
|
[NCBI]
|
8.57561e-05
|
|
|
PARK6
|
[NCBI]
|
8.57561e-05
|
|
|
NBIA1
|
[NCBI]
|
8.57561e-05
|
|
|
CCR5
|
[NCBI]
|
8.50457e-05
|
|
|
EPO
|
[NCBI]
|
8.43228e-05
|
|
|
SLC5A5
|
[NCBI]
|
8.41183e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
8.21382e-05
|
|
|
refsum disease
|
[NCBI]
|
8.21382e-05
|
|
|
RSMD1
|
[NCBI]
|
8.21382e-05
|
|
|
alkaptonuria
|
[NCBI]
|
8.21382e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
8.18874e-05
|
|
|
RP14
|
[NCBI]
|
8.18874e-05
|
|
|
hyperalphalipoproteinemia
|
[NCBI]
|
8.18874e-05
|
|
|
ATCAY
|
[NCBI]
|
8.18874e-05
|
|
|
EVA
|
[NCBI]
|
7.90045e-05
|
|
|
TH
|
[NCBI]
|
7.88062e-05
|
|
|
FBS
|
[NCBI]
|
7.87733e-05
|
|
|
alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity
|
[NCBI]
|
7.83856e-05
|
|
|
porphyria cutanea tarda, type i
|
[NCBI]
|
7.83856e-05
|
|
|
EPM3
|
[NCBI]
|
7.83856e-05
|
|
|
CDG1L
|
[NCBI]
|
7.83856e-05
|
|
|
transaldolase deficiency
|
[NCBI]
|
7.83856e-05
|
|
|
metachondromatosis
|
[NCBI]
|
7.83856e-05
|
|
|
CATCN3
|
[NCBI]
|
7.83856e-05
|
|
|
CISS1
|
[NCBI]
|
7.83856e-05
|
|
|
immunodeficiency due to defect in cd3-zeta
|
[NCBI]
|
7.83856e-05
|
|
|
aphakia, congenital primary
|
[NCBI]
|
7.83856e-05
|
|
|
NPHS3
|
[NCBI]
|
7.83856e-05
|
|
|
chondrodysplasia, acromesomelic, with genital anomalies
|
[NCBI]
|
7.83856e-05
|
|
|
fertile eunuch syndrome
|
[NCBI]
|
7.83856e-05
|
|
|
mitochondrial phosphate carrier deficiency
|
[NCBI]
|
7.83856e-05
|
|
|
DFNB53
|
[NCBI]
|
7.83856e-05
|
|
|
deafness, congenital, with inner ear agenesis, microtia, and microdontia
|
[NCBI]
|
7.83856e-05
|
|
|
dopamine beta-hydroxylase, plasma, thermolability of
|
[NCBI]
|
7.83856e-05
|
|
|
LCCS3
|
[NCBI]
|
7.83856e-05
|
|
|
cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome
|
[NCBI]
|
7.83856e-05
|
|
|
RCD3B
|
[NCBI]
|
7.83856e-05
|
|
|
CDG2E
|
[NCBI]
|
7.83856e-05
|
|
|
thyroid hormone metabolism, abnormal
|
[NCBI]
|
7.83856e-05
|
|
|
blood group--en
|
[NCBI]
|
7.83856e-05
|
|
|
RP36
|
[NCBI]
|
7.83856e-05
|
|
|
hypotrichosis-lymphedema-telangiectasia syndrome
|
[NCBI]
|
7.83856e-05
|
|
|
POF2B
|
[NCBI]
|
7.83856e-05
|
|
|
carabelli anomaly of maxillary molar teeth
|
[NCBI]
|
7.83856e-05
|
|
|
cortical dysplasia-focal epilepsy syndrome
|
[NCBI]
|
7.83856e-05
|
|
|
SMN2
|
[NCBI]
|
7.81712e-05
|
|
|
AR
|
[NCBI]
|
7.69335e-05
|
|
|
ALD
|
[NCBI]
|
7.52151e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
7.49477e-05
|
|
|
SMA3
|
[NCBI]
|
7.49477e-05
|
|
|
WFS1
|
[NCBI]
|
7.49477e-05
|
|
|
CCA2
|
[NCBI]
|
7.49028e-05
|
|
|
FMO2
|
[NCBI]
|
7.49028e-05
|
|
|
LGMD2J
|
[NCBI]
|
7.49028e-05
|
|
|
CHAT
|
[NCBI]
|
7.42327e-05
|
|
|
JARID2
|
[NCBI]
|
7.41322e-05
|
|
|
LYST
|
[NCBI]
|
7.41322e-05
|
|
|
FRDA
|
[NCBI]
|
7.32386e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
7.26877e-05
|
|
|
CAT
|
[NCBI]
|
7.21269e-05
|
|
|
ALAD
|
[NCBI]
|
7.08079e-05
|
|
|
CFH
|
[NCBI]
|
7.02941e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
6.99209e-05
|
|
|
CHED2
|
[NCBI]
|
6.90803e-05
|
|
|
mal de meleda
|
[NCBI]
|
6.90803e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
6.90803e-05
|
|
|
ACHM3
|
[NCBI]
|
6.90803e-05
|
|
|
APOB
|
[NCBI]
|
6.81282e-05
|
|
|
SLC4A1
|
[NCBI]
|
6.76759e-05
|
|
|
HPS3
|
[NCBI]
|
6.74514e-05
|
|
|
TNFSF6
|
[NCBI]
|
6.73979e-05
|
|
|
MBP
|
[NCBI]
|
6.67347e-05
|
|
|
LHCGR
|
[NCBI]
|
6.61333e-05
|
|
|
CDSP
|
[NCBI]
|
6.59604e-05
|
|
|
MPO
|
[NCBI]
|
6.59404e-05
|
|
|
PXE
|
[NCBI]
|
6.55181e-05
|
|
|
LAMA3
|
[NCBI]
|
6.52524e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
6.48499e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
6.42366e-05
|
|
|
osteogenic sarcoma
|
[NCBI]
|
6.41017e-05
|
|
|
RP12
|
[NCBI]
|
6.41017e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
6.41017e-05
|
|
|
OCA3
|
[NCBI]
|
6.41017e-05
|
|
|
DMC
|
[NCBI]
|
6.41017e-05
|
|
|
CLPED1
|
[NCBI]
|
6.41017e-05
|
|
|
NPHP3
|
[NCBI]
|
6.41017e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
6.41017e-05
|
|
|
GNRHR
|
[NCBI]
|
6.40098e-05
|
|
|
F2
|
[NCBI]
|
6.40098e-05
|
|
|
DGUOK
|
[NCBI]
|
6.27716e-05
|
|
|
HBD
|
[NCBI]
|
6.26629e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
6.25171e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
6.03038e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
5.97643e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
5.97643e-05
|
|
|
CLN8
|
[NCBI]
|
5.97643e-05
|
|
|
SCA6
|
[NCBI]
|
5.83049e-05
|
|
|
LWD
|
[NCBI]
|
5.83049e-05
|
|
|
SMA2
|
[NCBI]
|
5.81998e-05
|
|
|
CYP17A1
|
[NCBI]
|
5.81759e-05
|
|
|
AVP
|
[NCBI]
|
5.80285e-05
|
|
|
PD
|
[NCBI]
|
5.75673e-05
|
|
|
homocystinuria
|
[NCBI]
|
5.68426e-05
|
|
|
HBFQTL1
|
[NCBI]
|
5.61964e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
5.5931e-05
|
|
|
SCAR1
|
[NCBI]
|
5.5931e-05
|
|
|
OSMED
|
[NCBI]
|
5.5931e-05
|
|
|
WS3
|
[NCBI]
|
5.5931e-05
|
|
|
von willebrand disease
|
[NCBI]
|
5.55589e-05
|
|
|
CASR
|
[NCBI]
|
5.5504e-05
|
|
|
INVS
|
[NCBI]
|
5.49441e-05
|
|
|
WAS
|
[NCBI]
|
5.48887e-05
|
|
|
TSD
|
[NCBI]
|
5.46958e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
5.42859e-05
|
|
|
TUSC2
|
[NCBI]
|
5.38437e-05
|
|
|
DHFR
|
[NCBI]
|
5.35263e-05
|
|
|
HHF2
|
[NCBI]
|
5.29429e-05
|
|
|
AK1
|
[NCBI]
|
5.2933e-05
|
|
|
NPPA
|
[NCBI]
|
5.27948e-05
|
|
|
UCHL3
|
[NCBI]
|
5.25876e-05
|
|
|
CDA
|
[NCBI]
|
5.25045e-05
|
|
|
SACS
|
[NCBI]
|
5.25045e-05
|
|
|
carbamoyl phosphate synthetase i deficiency, hyperammonemia due to
|
[NCBI]
|
5.25045e-05
|
|
|
ALUNC
|
[NCBI]
|
5.25045e-05
|
|
|
SMA4
|
[NCBI]
|
5.25045e-05
|
|
|
LGMD2H
|
[NCBI]
|
5.25045e-05
|
|
|
PMDS
|
[NCBI]
|
5.25045e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
5.25045e-05
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
5.25045e-05
|
|
|
WS1
|
[NCBI]
|
5.16934e-05
|
|
|
LOCS
|
[NCBI]
|
5.10161e-05
|
|
|
cholesteryl ester transfer protein deficiency
|
[NCBI]
|
5.10161e-05
|
|
|
SIDDT
|
[NCBI]
|
5.10161e-05
|
|
|
cleft lip/palate with abnormal thumbs and microcephaly
|
[NCBI]
|
5.10161e-05
|
|
|
caspase 8 deficiency
|
[NCBI]
|
5.10161e-05
|
|
|
bruck syndrome 2
|
[NCBI]
|
5.10161e-05
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
5.10161e-05
|
|
|
eem syndrome
|
[NCBI]
|
5.10161e-05
|
|
|
parkinson-dementia syndrome
|
[NCBI]
|
5.10161e-05
|
|
|
SLSN4
|
[NCBI]
|
5.10161e-05
|
|
|
retinopathy, pigmentary, and mental retardation
|
[NCBI]
|
5.10161e-05
|
|
|
CMH8
|
[NCBI]
|
5.10161e-05
|
|
|
JBTS4
|
[NCBI]
|
5.10161e-05
|
|
|
MRT6
|
[NCBI]
|
5.10161e-05
|
|
|
craniofacial dysmorphism with ocular coloboma, absent corpus callosum, and aortic dilatation
|
[NCBI]
|
5.10161e-05
|
|
|
glycinuria with or without oxalate urolithiasis
|
[NCBI]
|
5.10161e-05
|
|
|
abcd syndrome
|
[NCBI]
|
5.10161e-05
|
|
|
methylmalonyl-coa epimerase deficiency
|
[NCBI]
|
5.10161e-05
|
|
|
LCCS2
|
[NCBI]
|
5.10161e-05
|
|
|
MCPH3
|
[NCBI]
|
5.10161e-05
|
|
|
t-cell subgroups, non-hla-linked
|
[NCBI]
|
5.10161e-05
|
|
|
magnesium, elevated red cell
|
[NCBI]
|
5.10161e-05
|
|
|
hypercholesterolemia, autosomal dominant, type b
|
[NCBI]
|
5.10161e-05
|
|
|
AOIII
|
[NCBI]
|
5.10161e-05
|
|
|
chorea, benign familial
|
[NCBI]
|
5.10161e-05
|
|
|
TSHB
|
[NCBI]
|
5.04916e-05
|
|
|
TRIM32
|
[NCBI]
|
4.96054e-05
|
|
|
alzheimer disease 2
|
[NCBI]
|
4.94134e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
4.94134e-05
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
4.94134e-05
|
|
|
ACCPN
|
[NCBI]
|
4.94134e-05
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
4.94134e-05
|
|
|
amyloidosis v
|
[NCBI]
|
4.94134e-05
|
|
|
NCIE1
|
[NCBI]
|
4.94134e-05
|
|
|
VHL
|
[NCBI]
|
4.8363e-05
|
|
|
FANCA
|
[NCBI]
|
4.7969e-05
|
|
|
TPI1
|
[NCBI]
|
4.72285e-05
|
|
|
ADRB2
|
[NCBI]
|
4.72285e-05
|
|
|
TS
|
[NCBI]
|
4.69396e-05
|
|
|
HR
|
[NCBI]
|
4.68028e-05
|
|
|
GCCD1
|
[NCBI]
|
4.66035e-05
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
4.66035e-05
|
|
|
SPD1
|
[NCBI]
|
4.66035e-05
|
|
|
JLNS1
|
[NCBI]
|
4.66035e-05
|
|
|
USH1C
|
[NCBI]
|
4.66035e-05
|
|
|
LGMD1B
|
[NCBI]
|
4.66035e-05
|
|
|
TPMT
|
[NCBI]
|
4.64508e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
4.63766e-05
|
|
|
RTT
|
[NCBI]
|
4.60536e-05
|
|
|
ATP7B
|
[NCBI]
|
4.58101e-05
|
|
|
MC2R
|
[NCBI]
|
4.57028e-05
|
|
|
FA
|
[NCBI]
|
4.56298e-05
|
|
|
RB1
|
[NCBI]
|
4.51624e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
4.40327e-05
|
|
|
nondisjunction
|
[NCBI]
|
4.40327e-05
|
|
|
MCPH1
|
[NCBI]
|
4.40327e-05
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
4.40327e-05
|
|
|
LGMD2B
|
[NCBI]
|
4.40327e-05
|
|
|
HEXB
|
[NCBI]
|
4.38239e-05
|
|
|
PMM2
|
[NCBI]
|
4.36613e-05
|
|
|
PINK1
|
[NCBI]
|
4.36613e-05
|
|
|
POLG
|
[NCBI]
|
4.31961e-05
|
|
|
NPHP1
|
[NCBI]
|
4.29401e-05
|
|
|
AS
|
[NCBI]
|
4.28482e-05
|
|
|
FKRP
|
[NCBI]
|
4.27108e-05
|
|
|
SLC3A1
|
[NCBI]
|
4.27108e-05
|
|
|
PPM1B
|
[NCBI]
|
4.25478e-05
|
|
|
LMNA
|
[NCBI]
|
4.21727e-05
|
|
|
LPL
|
[NCBI]
|
4.16826e-05
|
|
|
FED
|
[NCBI]
|
4.16681e-05
|
|
|
hartnup disorder
|
[NCBI]
|
4.16681e-05
|
|
|
PPAC
|
[NCBI]
|
4.16681e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
4.16681e-05
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
4.16486e-05
|
|
|
IDDM
|
[NCBI]
|
4.15825e-05
|
|
|
SLC7A9
|
[NCBI]
|
4.12049e-05
|
|
|
MCPH6
|
[NCBI]
|
4.09374e-05
|
|
|
polydactyly
|
[NCBI]
|
4.09374e-05
|
|
|
OODD
|
[NCBI]
|
4.09374e-05
|
|
|
ABSD
|
[NCBI]
|
4.09374e-05
|
|
|
fibular hypoplasia and complex brachydactyly
|
[NCBI]
|
4.09374e-05
|
|
|
spherocytosis, autosomal recessive
|
[NCBI]
|
4.09374e-05
|
|
|
DFNB21
|
[NCBI]
|
4.09374e-05
|
|
|
icos deficiency
|
[NCBI]
|
4.09374e-05
|
|
|
abdominal body fat distribution
|
[NCBI]
|
4.09374e-05
|
|
|
S CHOICE OF
|
[NCBI]
|
4.09374e-05
|
|
|
lathosterolosis
|
[NCBI]
|
4.09374e-05
|
|
|
DFNB31
|
[NCBI]
|
4.09374e-05
|
|
|
phosphoglycerate dehydrogenase deficiency
|
[NCBI]
|
4.09374e-05
|
|
|
PLT1
|
[NCBI]
|
4.09374e-05
|
|
|
angioid streaks
|
[NCBI]
|
4.09374e-05
|
|
|
ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis
|
[NCBI]
|
4.09374e-05
|
|
|
ovarian teratoma
|
[NCBI]
|
4.09374e-05
|
|
|
majeed syndrome
|
[NCBI]
|
4.09374e-05
|
|
|
NEK1
|
[NCBI]
|
4.09374e-05
|
|
|
HJMD
|
[NCBI]
|
4.09374e-05
|
|
|
amelogenesis imperfecta, hypoplastic, and openbite malocclusion, autosomal recessive
|
[NCBI]
|
4.09374e-05
|
|
|
SMC
|
[NCBI]
|
4.09374e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
4.09374e-05
|
|
|
camptodactyly, tall stature, and hearing loss syndrome
|
[NCBI]
|
4.09374e-05
|
|
|
CMD1P
|
[NCBI]
|
4.09374e-05
|
|
|
LCA10
|
[NCBI]
|
4.09374e-05
|
|
|
OCA1A
|
[NCBI]
|
4.03343e-05
|
|
|
ZS
|
[NCBI]
|
4.02385e-05
|
|
|
PROP1
|
[NCBI]
|
4.00962e-05
|
|
|
MTAP
|
[NCBI]
|
3.9737e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
3.9737e-05
|
|
|
MKKS
|
[NCBI]
|
3.94827e-05
|
|
|
PHA
|
[NCBI]
|
3.94827e-05
|
|
|
CORD2
|
[NCBI]
|
3.94827e-05
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
3.94827e-05
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
3.94827e-05
|
|
|
blood group, p system
|
[NCBI]
|
3.94827e-05
|
|
|
AHR
|
[NCBI]
|
3.94562e-05
|
|
|
COL17A1
|
[NCBI]
|
3.9294e-05
|
|
|
CDK4
|
[NCBI]
|
3.91882e-05
|
|
|
GHR
|
[NCBI]
|
3.83549e-05
|
|
|
HLA-C
|
[NCBI]
|
3.82045e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
3.81259e-05
|
|
|
LPI
|
[NCBI]
|
3.80778e-05
|
|
|
HHF1
|
[NCBI]
|
3.78463e-05
|
|
|
MODY
|
[NCBI]
|
3.77871e-05
|
|
|
EDN3
|
[NCBI]
|
3.7779e-05
|
|
|
ITGA9
|
[NCBI]
|
3.7478e-05
|
|
|
PEX16
|
[NCBI]
|
3.7478e-05
|
|
|
PREPL
|
[NCBI]
|
3.7478e-05
|
|
|
pituitary dwarfism i
|
[NCBI]
|
3.74547e-05
|
|
|
CETP
|
[NCBI]
|
3.70623e-05
|
|
|
SMAD4
|
[NCBI]
|
3.70623e-05
|
|
|
FUT1
|
[NCBI]
|
3.68895e-05
|
|
|
S100A8
|
[NCBI]
|
3.68895e-05
|
|
|
CLEC4M
|
[NCBI]
|
3.68895e-05
|
|
|
C3
|
[NCBI]
|
3.67193e-05
|
|
|
RECQL3
|
[NCBI]
|
3.63704e-05
|
|
|
MBL2
|
[NCBI]
|
3.62734e-05
|
|
|
LEP
|
[NCBI]
|
3.60485e-05
|
|
|
SLC2A2
|
[NCBI]
|
3.5795e-05
|
|
|
AGL
|
[NCBI]
|
3.56739e-05
|
|
|
NPHP1
|
[NCBI]
|
3.55662e-05
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
3.55299e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
3.55016e-05
|
|
|
HLA-A
|
[NCBI]
|
3.51629e-05
|
|
|
BDNF
|
[NCBI]
|
3.50812e-05
|
|
|
GLB1
|
[NCBI]
|
3.50554e-05
|
|
|
PPOX
|
[NCBI]
|
3.50554e-05
|
|
|
GAPDH
|
[NCBI]
|
3.46274e-05
|
|
|
SGCA
|
[NCBI]
|
3.45443e-05
|
|
|
CYP2C9
|
[NCBI]
|
3.45443e-05
|
|
|
IGAD2
|
[NCBI]
|
3.45341e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
3.45341e-05
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
3.45341e-05
|
|
|
glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to
|
[NCBI]
|
3.45341e-05
|
|
|
charcot-marie-tooth disease, recessive intermediate a
|
[NCBI]
|
3.45341e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, infantile
|
[NCBI]
|
3.45341e-05
|
|
|
CFEOM2
|
[NCBI]
|
3.45341e-05
|
|
|
MLASA
|
[NCBI]
|
3.45341e-05
|
|
|
fragile site 17p12
|
[NCBI]
|
3.45341e-05
|
|
|
caudal duplication anomaly
|
[NCBI]
|
3.45341e-05
|
|
|
myxoma, intracardiac
|
[NCBI]
|
3.45341e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
3.45341e-05
|
|
|
resting heart rate
|
[NCBI]
|
3.45341e-05
|
|
|
RP18
|
[NCBI]
|
3.45341e-05
|
|
|
USH1G
|
[NCBI]
|
3.45341e-05
|
|
|
CMT4H
|
[NCBI]
|
3.45341e-05
|
|
|
bare lymphocyte syndrome, type i
|
[NCBI]
|
3.45341e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
3.45341e-05
|
|
|
weill-marchesani syndrome, autosomal dominant
|
[NCBI]
|
3.45341e-05
|
|
|
USH1F
|
[NCBI]
|
3.45341e-05
|
|
|
PURE&apos
|
[NCBI]
|
3.45341e-05
|
|
|
DFNB59
|
[NCBI]
|
3.45341e-05
|
|
|
RP19
|
[NCBI]
|
3.45341e-05
|
|
|
hydroxyprolinemia
|
[NCBI]
|
3.45341e-05
|
|
|
hyperlysinemia
|
[NCBI]
|
3.45341e-05
|
|
|
segawa syndrome, autosomal recessive
|
[NCBI]
|
3.45341e-05
|
|
|
CDKN2A
|
[NCBI]
|
3.42694e-05
|
|
|
ITGB3
|
[NCBI]
|
3.40521e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
3.40521e-05
|
|
|
HYAL1
|
[NCBI]
|
3.40179e-05
|
|
|
CSMD1
|
[NCBI]
|
3.40179e-05
|
|
|
C1S
|
[NCBI]
|
3.40179e-05
|
|
|
ECEL1
|
[NCBI]
|
3.40179e-05
|
|
|
MYO7A
|
[NCBI]
|
3.38232e-05
|
|
|
EL1
|
[NCBI]
|
3.38019e-05
|
|
|
MSS
|
[NCBI]
|
3.38019e-05
|
|
|
RNASEL
|
[NCBI]
|
3.34899e-05
|
|
|
RAD51
|
[NCBI]
|
3.34899e-05
|
|
|
PAX1
|
[NCBI]
|
3.34899e-05
|
|
|
HBA2
|
[NCBI]
|
3.34871e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
3.3368e-05
|
|
|
SLC26A4
|
[NCBI]
|
3.32352e-05
|
|
|
RECQL2
|
[NCBI]
|
3.26647e-05
|
|
|
wolman disease
|
[NCBI]
|
3.26647e-05
|
|
|
MAFD2
|
[NCBI]
|
3.25033e-05
|
|
|
UCHL1
|
[NCBI]
|
3.25017e-05
|
|
|
PTS
|
[NCBI]
|
3.25017e-05
|
|
|
GLC3A
|
[NCBI]
|
3.2149e-05
|
|
|
CGL2
|
[NCBI]
|
3.2149e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
3.2149e-05
|
|
|
UCMD
|
[NCBI]
|
3.2149e-05
|
|
|
ADRB3
|
[NCBI]
|
3.15724e-05
|
|
|
COL11A2
|
[NCBI]
|
3.15724e-05
|
|
|
ECM1
|
[NCBI]
|
3.15724e-05
|
|
|
KIR2DL3
|
[NCBI]
|
3.13815e-05
|
|
|
MPV17
|
[NCBI]
|
3.13815e-05
|
|
|
HSD17B3
|
[NCBI]
|
3.13815e-05
|
|
|
TALDO1
|
[NCBI]
|
3.13815e-05
|
|
|
ARL6
|
[NCBI]
|
3.13815e-05
|
|
|
ALG6
|
[NCBI]
|
3.13815e-05
|
|
|
AGPAT2
|
[NCBI]
|
3.13815e-05
|
|
|
GIST
|
[NCBI]
|
3.1324e-05
|
|
|
TTR
|
[NCBI]
|
3.1043e-05
|
|
|
DHCR7
|
[NCBI]
|
3.06956e-05
|
|
|
donohue syndrome
|
[NCBI]
|
3.05967e-05
|
|
|
MDC1A
|
[NCBI]
|
3.05967e-05
|
|
|
CHAC
|
[NCBI]
|
3.05967e-05
|
|
|
ABCA4
|
[NCBI]
|
3.05399e-05
|
|
|
PPARA
|
[NCBI]
|
3.05204e-05
|
|
|
CPI
|
[NCBI]
|
3.04189e-05
|
|
|
MC1R
|
[NCBI]
|
3.00211e-05
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
2.99387e-05
|
|
|
RCDP3
|
[NCBI]
|
2.98764e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
2.98764e-05
|
|
|
fragile site 10q25
|
[NCBI]
|
2.98764e-05
|
|
|
RCD3A
|
[NCBI]
|
2.98764e-05
|
|
|
CACP
|
[NCBI]
|
2.98764e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
2.98764e-05
|
|
|
schindler disease, type i
|
[NCBI]
|
2.98764e-05
|
|
|
PFIC2
|
[NCBI]
|
2.98764e-05
|
|
|
n-acetylglutamate synthase deficiency
|
[NCBI]
|
2.98764e-05
|
|
|
NEM1
|
[NCBI]
|
2.98764e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
2.98764e-05
|
|
|
glycogen storage disease 0, muscle
|
[NCBI]
|
2.98764e-05
|
|
|
thrombophilia due to deficiency of activated protein c cofactor
|
[NCBI]
|
2.98764e-05
|
|
|
west nile virus, susceptibility to
|
[NCBI]
|
2.98764e-05
|
|
|
follicle-stimulating hormone deficiency, isolated
|
[NCBI]
|
2.98764e-05
|
|
|
DFNA13
|
[NCBI]
|
2.98764e-05
|
|
|
OUBR
|
[NCBI]
|
2.98764e-05
|
|
|
RTADR
|
[NCBI]
|
2.98764e-05
|
|
|
NN
|
[NCBI]
|
2.98764e-05
|
|
|
LI2
|
[NCBI]
|
2.98764e-05
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
2.98764e-05
|
|
|
premature chromosome condensation with microcephaly and mental retardation
|
[NCBI]
|
2.98764e-05
|
|
|
mucopolysaccharidosis type iiid
|
[NCBI]
|
2.98764e-05
|
|
|
DFNB2
|
[NCBI]
|
2.98764e-05
|
|
|
spondylocarpotarsal synostosis syndrome
|
[NCBI]
|
2.98764e-05
|
|
|
cystinosis, adult nonnephropathic
|
[NCBI]
|
2.98764e-05
|
|
|
DFNB6
|
[NCBI]
|
2.98764e-05
|
|
|
NPHP4
|
[NCBI]
|
2.98764e-05
|
|
|
budd-chiari syndrome
|
[NCBI]
|
2.98764e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
2.98764e-05
|
|
|
AH
|
[NCBI]
|
2.98764e-05
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
2.98764e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
2.98764e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 1
|
[NCBI]
|
2.98764e-05
|
|
|
LCA2
|
[NCBI]
|
2.98764e-05
|
|
|
PDB1
|
[NCBI]
|
2.98764e-05
|
|
|
mitochondrial complex ii deficiency
|
[NCBI]
|
2.98764e-05
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
2.98764e-05
|
|
|
CLN3
|
[NCBI]
|
2.98661e-05
|
|
|
CPT2
|
[NCBI]
|
2.98661e-05
|
|
|
FTO
|
[NCBI]
|
2.92521e-05
|
|
|
HAND1
|
[NCBI]
|
2.92521e-05
|
|
|
SLURP1
|
[NCBI]
|
2.92521e-05
|
|
|
C1QG
|
[NCBI]
|
2.92521e-05
|
|
|
CLN8
|
[NCBI]
|
2.92521e-05
|
|
|
ARIX
|
[NCBI]
|
2.92521e-05
|
|
|
FGA
|
[NCBI]
|
2.91865e-05
|
|
|
CSNB1A
|
[NCBI]
|
2.91356e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
2.91356e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
2.91356e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
2.91356e-05
|
|
|
HOXD13
|
[NCBI]
|
2.90793e-05
|
|
|
AMPD1
|
[NCBI]
|
2.90793e-05
|
|
|
FRAP1
|
[NCBI]
|
2.89502e-05
|
|
|
SHBG
|
[NCBI]
|
2.89488e-05
|
|
|
FSHMD1A
|
[NCBI]
|
2.87716e-05
|
|
|
PTK2
|
[NCBI]
|
2.8552e-05
|
|
|
galactosemia
|
[NCBI]
|
2.85485e-05
|
|
|
APOA1
|
[NCBI]
|
2.85277e-05
|
|
|
WFS1
|
[NCBI]
|
2.83314e-05
|
|
|
LAMB3
|
[NCBI]
|
2.83314e-05
|
|
|
XDH
|
[NCBI]
|
2.80992e-05
|
|
|
CMM2
|
[NCBI]
|
2.77575e-05
|
|
|
obesity
|
[NCBI]
|
2.76733e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
2.76733e-05
|
|
|
LHB
|
[NCBI]
|
2.76189e-05
|
|
|
PCOS1
|
[NCBI]
|
2.75264e-05
|
|
|
PTHLH
|
[NCBI]
|
2.74768e-05
|
|
|
SIL1
|
[NCBI]
|
2.74679e-05
|
|
|
LPIN2
|
[NCBI]
|
2.74679e-05
|
|
|
TCF21
|
[NCBI]
|
2.74679e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
2.74126e-05
|
|
|
SRD5A2
|
[NCBI]
|
2.69389e-05
|
|
|
dedicator of cytokinesis 4
|
[NCBI]
|
2.69207e-05
|
|
|
HSPA12B
|
[NCBI]
|
2.69207e-05
|
|
|
101f6 gene
|
[NCBI]
|
2.69207e-05
|
|
|
MOSPD3
|
[NCBI]
|
2.69207e-05
|
|
|
CISD2
|
[NCBI]
|
2.69207e-05
|
|
|
AASS
|
[NCBI]
|
2.69207e-05
|
|
|
KCTD7
|
[NCBI]
|
2.69207e-05
|
|
|
IZUMO1
|
[NCBI]
|
2.69207e-05
|
|
|
BBS12
|
[NCBI]
|
2.69207e-05
|
|
|
pl6 gene
|
[NCBI]
|
2.69207e-05
|
|
|
C2ORF34
|
[NCBI]
|
2.69207e-05
|
|
|
HOXA3
|
[NCBI]
|
2.69207e-05
|
|
|
MFSD8
|
[NCBI]
|
2.69207e-05
|
|
|
SERF2
|
[NCBI]
|
2.69207e-05
|
|
|
MOSPD1
|
[NCBI]
|
2.69207e-05
|
|
|
FEA
|
[NCBI]
|
2.69207e-05
|
|
|
TUSC1
|
[NCBI]
|
2.69207e-05
|
|
|
TUSC4
|
[NCBI]
|
2.69207e-05
|
|
|
SPATA16
|
[NCBI]
|
2.69207e-05
|
|
|
PLCL1
|
[NCBI]
|
2.69207e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.67687e-05
|
|
|
LS
|
[NCBI]
|
2.67687e-05
|
|
|
HS
|
[NCBI]
|
2.64993e-05
|
|
|
ATM
|
[NCBI]
|
2.64977e-05
|
|
|
PBD
|
[NCBI]
|
2.64554e-05
|
|
|
GALC
|
[NCBI]
|
2.62888e-05
|
|
|
pta deficiency
|
[NCBI]
|
2.62888e-05
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
2.62468e-05
|
|
|
MRT1
|
[NCBI]
|
2.62468e-05
|
|
|
paget disease, juvenile
|
[NCBI]
|
2.62468e-05
|
|
|
FANCD1
|
[NCBI]
|
2.62468e-05
|
|
|
OCA4
|
[NCBI]
|
2.62468e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
2.62468e-05
|
|
|
LGMD2F
|
[NCBI]
|
2.62468e-05
|
|
|
naxos disease
|
[NCBI]
|
2.62468e-05
|
|
|
thrombophilia
|
[NCBI]
|
2.62468e-05
|
|
|
oguchi disease
|
[NCBI]
|
2.62468e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
2.62468e-05
|
|
|
RCDP2
|
[NCBI]
|
2.62468e-05
|
|
|
ectodermal dysplasia/skin fragility syndrome
|
[NCBI]
|
2.62468e-05
|
|
|
CGL1
|
[NCBI]
|
2.62468e-05
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
2.62468e-05
|
|
|
CMRD
|
[NCBI]
|
2.62468e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
2.62468e-05
|
|
|
boomerang dysplasia
|
[NCBI]
|
2.62468e-05
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
2.62468e-05
|
|
|
tyrosinemia, type iii
|
[NCBI]
|
2.62468e-05
|
|
|
USH2C
|
[NCBI]
|
2.62468e-05
|
|
|
F13A1
|
[NCBI]
|
2.61017e-05
|
|
|
TK2
|
[NCBI]
|
2.59342e-05
|
|
|
LAMC2
|
[NCBI]
|
2.59342e-05
|
|
|
PRH2
|
[NCBI]
|
2.59342e-05
|
|
|
BSCL2
|
[NCBI]
|
2.59342e-05
|
|
|
DMD
|
[NCBI]
|
2.56795e-05
|
|
|
SLC22A5
|
[NCBI]
|
2.56662e-05
|
|
|
GSTM1
|
[NCBI]
|
2.56662e-05
|
|
|
osteoarthritis
|
[NCBI]
|
2.52231e-05
|
|
|
ALMS
|
[NCBI]
|
2.52231e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
2.52036e-05
|
|
|
CHRNE
|
[NCBI]
|
2.50692e-05
|
|
|
GNRH1
|
[NCBI]
|
2.46189e-05
|
|
|
KCNJ6
|
[NCBI]
|
2.45909e-05
|
|
|
GSTT1
|
[NCBI]
|
2.45909e-05
|
|
|
CDH3
|
[NCBI]
|
2.45909e-05
|
|
|
LMBR1
|
[NCBI]
|
2.45909e-05
|
|
|
CLDN16
|
[NCBI]
|
2.45909e-05
|
|
|
FGF5
|
[NCBI]
|
2.45909e-05
|
|
|
ATP8B1
|
[NCBI]
|
2.45909e-05
|
|
|
HTRA1
|
[NCBI]
|
2.45909e-05
|
|
|
ALMS1
|
[NCBI]
|
2.45909e-05
|
|
|
LMAN1
|
[NCBI]
|
2.45909e-05
|
|
|
FABP2
|
[NCBI]
|
2.44958e-05
|
|
|
KRT14
|
[NCBI]
|
2.44958e-05
|
|
|
RCDP1
|
[NCBI]
|
2.4055e-05
|
|
|
CHS
|
[NCBI]
|
2.39079e-05
|
|
|
HBA1
|
[NCBI]
|
2.3805e-05
|
|
|
hurler syndrome
|
[NCBI]
|
2.36768e-05
|
|
|
KCNJ11
|
[NCBI]
|
2.34138e-05
|
|
|
DPYD
|
[NCBI]
|
2.34138e-05
|
|
|
SECISBP2
|
[NCBI]
|
2.33974e-05
|
|
|
GP9
|
[NCBI]
|
2.33974e-05
|
|
|
INHA
|
[NCBI]
|
2.33974e-05
|
|
|
SGCG
|
[NCBI]
|
2.33974e-05
|
|
|
C1QA
|
[NCBI]
|
2.33974e-05
|
|
|
HADH
|
[NCBI]
|
2.33974e-05
|
|
|
PKP1
|
[NCBI]
|
2.33974e-05
|
|
|
cerebral palsy, spastic, symmetric, autosomal recessive
|
[NCBI]
|
2.32965e-05
|
|
|
CLN6
|
[NCBI]
|
2.32965e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
2.32965e-05
|
|
|
HMS
|
[NCBI]
|
2.32965e-05
|
|
|
SPMM
|
[NCBI]
|
2.32965e-05
|
|
|
agammaglobulinemia, non-bruton type, autosomal recessive
|
[NCBI]
|
2.32965e-05
|
|
|
MCOPS9
|
[NCBI]
|
2.32965e-05
|
|
|
three m syndrome
|
[NCBI]
|
2.32965e-05
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
2.32965e-05
|
|
|
STL2
|
[NCBI]
|
2.32965e-05
|
|
|
EAD
|
[NCBI]
|
2.32965e-05
|
|
|
CO
|
[NCBI]
|
2.32965e-05
|
|
|
DSAP1
|
[NCBI]
|
2.32965e-05
|
|
|
CDG1C
|
[NCBI]
|
2.32965e-05
|
|
|
winchester syndrome
|
[NCBI]
|
2.32965e-05
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
2.32965e-05
|
|
|
aplastic anemia
|
[NCBI]
|
2.32965e-05
|
|
|
pierson syndrome
|
[NCBI]
|
2.32965e-05
|
|
|
WT5
|
[NCBI]
|
2.32965e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
2.32965e-05
|
|
|
ARMD7
|
[NCBI]
|
2.32965e-05
|
|
|
weill-marchesani syndrome, autosomal recessive
|
[NCBI]
|
2.32965e-05
|
|
|
INSR
|
[NCBI]
|
2.32632e-05
|
|
|
F3
|
[NCBI]
|
2.31313e-05
|
|
|
PPSH
|
[NCBI]
|
2.29464e-05
|
|
|
SPDA1
|
[NCBI]
|
2.29464e-05
|
|
|
POF1
|
[NCBI]
|
2.29464e-05
|
|
|
NOS3
|
[NCBI]
|
2.2884e-05
|
|
|
LEPR
|
[NCBI]
|
2.26694e-05
|
|
|
DYSF
|
[NCBI]
|
2.24088e-05
|
|
|
LCAT
|
[NCBI]
|
2.23402e-05
|
|
|
MYO15A
|
[NCBI]
|
2.23246e-05
|
|
|
FMN
|
[NCBI]
|
2.23246e-05
|
|
|
loc387715 gene
|
[NCBI]
|
2.23246e-05
|
|
|
HPS1
|
[NCBI]
|
2.23246e-05
|
|
|
SCN8A
|
[NCBI]
|
2.23246e-05
|
|
|
CX3CR1
|
[NCBI]
|
2.23246e-05
|
|
|
MERTK
|
[NCBI]
|
2.23246e-05
|
|
|
SPTA1
|
[NCBI]
|
2.22455e-05
|
|
|
WBS
|
[NCBI]
|
2.19515e-05
|
|
|
STGD1
|
[NCBI]
|
2.18928e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
2.18928e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.15147e-05
|
|
|
GSN
|
[NCBI]
|
2.14718e-05
|
|
|
FCGR2B
|
[NCBI]
|
2.13514e-05
|
|
|
WWOX
|
[NCBI]
|
2.13514e-05
|
|
|
GDF11
|
[NCBI]
|
2.13514e-05
|
|
|
DYRK1A
|
[NCBI]
|
2.13514e-05
|
|
|
CYP2A6
|
[NCBI]
|
2.10262e-05
|
|
|
STL1
|
[NCBI]
|
2.08904e-05
|
|
|
cystathioninuria
|
[NCBI]
|
2.0829e-05
|
|
|
TRMA
|
[NCBI]
|
2.0829e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
2.0829e-05
|
|
|
FANCB
|
[NCBI]
|
2.0829e-05
|
|
|
HRD
|
[NCBI]
|
2.0829e-05
|
|
|
KCS
|
[NCBI]
|
2.0829e-05
|
|
|
HPS2
|
[NCBI]
|
2.0829e-05
|
|
|
globozoospermia
|
[NCBI]
|
2.0829e-05
|
|
|
AOI
|
[NCBI]
|
2.0829e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
2.0829e-05
|
|
|
JBTS3
|
[NCBI]
|
2.0829e-05
|
|
|
MDC1C
|
[NCBI]
|
2.0829e-05
|
|
|
GS1
|
[NCBI]
|
2.0829e-05
|
|
|
vitiligo
|
[NCBI]
|
2.0829e-05
|
|
|
EPD
|
[NCBI]
|
2.0829e-05
|
|
|
CMT4B1
|
[NCBI]
|
2.0829e-05
|
|
|
coproporphyria
|
[NCBI]
|
2.05949e-05
|
|
|
CDX2
|
[NCBI]
|
2.04618e-05
|
|
|
EIF2B5
|
[NCBI]
|
2.04618e-05
|
|
|
NCF2
|
[NCBI]
|
2.04618e-05
|
|
|
RASSF1
|
[NCBI]
|
2.04618e-05
|
|
|
PVRL1
|
[NCBI]
|
2.04618e-05
|
|
|
HLCS
|
[NCBI]
|
2.04618e-05
|
|
|
COL9A1
|
[NCBI]
|
2.04618e-05
|
|
|
NQO1
|
[NCBI]
|
2.04618e-05
|
|
|
prekallikrein deficiency
|
[NCBI]
|
2.04618e-05
|
|
|
ACADS
|
[NCBI]
|
2.0177e-05
|
|
|
ASPA
|
[NCBI]
|
2.0177e-05
|
|
|
APOC2
|
[NCBI]
|
2.0177e-05
|
|
|
RBS
|
[NCBI]
|
1.99358e-05
|
|
|
PTPRC
|
[NCBI]
|
1.97718e-05
|
|
|
PDE6B
|
[NCBI]
|
1.97718e-05
|
|
|
MC4R
|
[NCBI]
|
1.96495e-05
|
|
|
BCKDHA
|
[NCBI]
|
1.96431e-05
|
|
|
P2RX7
|
[NCBI]
|
1.96431e-05
|
|
|
PRX
|
[NCBI]
|
1.96431e-05
|
|
|
BTD
|
[NCBI]
|
1.96431e-05
|
|
|
SPP1
|
[NCBI]
|
1.96122e-05
|
|
|
THRB
|
[NCBI]
|
1.93859e-05
|
|
|
RHCE
|
[NCBI]
|
1.93787e-05
|
|
|
AGTR1
|
[NCBI]
|
1.93787e-05
|
|
|
EDNRB
|
[NCBI]
|
1.93787e-05
|
|
|
CJD
|
[NCBI]
|
1.92218e-05
|
|
|
LRRK2
|
[NCBI]
|
1.91268e-05
|
|
|
DJS
|
[NCBI]
|
1.90258e-05
|
|
|
FY
|
[NCBI]
|
1.8997e-05
|
|
|
SLOS
|
[NCBI]
|
1.89705e-05
|
|
|
OTOF
|
[NCBI]
|
1.88857e-05
|
|
|
TULP1
|
[NCBI]
|
1.88857e-05
|
|
|
ME2
|
[NCBI]
|
1.88857e-05
|
|
|
KRTHB5
|
[NCBI]
|
1.87379e-05
|
|
|
TMIE
|
[NCBI]
|
1.87379e-05
|
|
|
COG7
|
[NCBI]
|
1.87379e-05
|
|
|
PRCD
|
[NCBI]
|
1.87379e-05
|
|
|
OTOA
|
[NCBI]
|
1.87379e-05
|
|
|
ichthyin
|
[NCBI]
|
1.87379e-05
|
|
|
ZMYND10
|
[NCBI]
|
1.87379e-05
|
|
|
TAS2R38
|
[NCBI]
|
1.87379e-05
|
|
|
TMEM113
|
[NCBI]
|
1.87379e-05
|
|
|
UNC13A
|
[NCBI]
|
1.87379e-05
|
|
|
TTC8
|
[NCBI]
|
1.87379e-05
|
|
|
SLC38A3
|
[NCBI]
|
1.87379e-05
|
|
|
BBS7
|
[NCBI]
|
1.87379e-05
|
|
|
NID2
|
[NCBI]
|
1.87379e-05
|
|
|
fus2 gene
|
[NCBI]
|
1.87379e-05
|
|
|
BAP1
|
[NCBI]
|
1.87379e-05
|
|
|
HSPA12A
|
[NCBI]
|
1.87379e-05
|
|
|
BCL2L2
|
[NCBI]
|
1.87379e-05
|
|
|
brain-specific protein pc-1
|
[NCBI]
|
1.87379e-05
|
|
|
CTPP4
|
[NCBI]
|
1.87379e-05
|
|
|
SERF1A
|
[NCBI]
|
1.87379e-05
|
|
|
KCNV2
|
[NCBI]
|
1.87379e-05
|
|
|
RAB36
|
[NCBI]
|
1.87379e-05
|
|
|
MCEE
|
[NCBI]
|
1.87379e-05
|
|
|
DVL1L1
|
[NCBI]
|
1.87379e-05
|
|
|
PRKAG3
|
[NCBI]
|
1.87379e-05
|
|
|
IFRD2
|
[NCBI]
|
1.87379e-05
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
1.87226e-05
|
|
|
GGM
|
[NCBI]
|
1.87226e-05
|
|
|
iron overload in africa
|
[NCBI]
|
1.87226e-05
|
|
|
HFE3
|
[NCBI]
|
1.87226e-05
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
1.87226e-05
|
|
|
BOCD
|
[NCBI]
|
1.87226e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
1.87226e-05
|
|
|
GS2
|
[NCBI]
|
1.87226e-05
|
|
|
EDM4
|
[NCBI]
|
1.87226e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
1.87226e-05
|
|
|
MODY2
|
[NCBI]
|
1.87226e-05
|
|
|
emanuel syndrome
|
[NCBI]
|
1.87226e-05
|
|
|
LRS1
|
[NCBI]
|
1.87226e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
1.87226e-05
|
|
|
IS
|
[NCBI]
|
1.87226e-05
|
|
|
RHN
|
[NCBI]
|
1.87226e-05
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
1.87226e-05
|
|
|
elliptocytosis, rhesus-unlinked type
|
[NCBI]
|
1.87226e-05
|
|
|
morquio syndrome b
|
[NCBI]
|
1.87226e-05
|
|
|
NSHPT
|
[NCBI]
|
1.87226e-05
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
1.87226e-05
|
|
|
PARK2
|
[NCBI]
|
1.86215e-05
|
|
|
HGPS
|
[NCBI]
|
1.83836e-05
|
|
|
AIS
|
[NCBI]
|
1.83531e-05
|
|
|
HSCR1
|
[NCBI]
|
1.83112e-05
|
|
|
PANK2
|
[NCBI]
|
1.81814e-05
|
|
|
ADRB1
|
[NCBI]
|
1.81814e-05
|
|
|
CAMK2A
|
[NCBI]
|
1.81814e-05
|
|
|
PARK2
|
[NCBI]
|
1.81575e-05
|
|
|
DRPLA
|
[NCBI]
|
1.80823e-05
|
|
|
VDR
|
[NCBI]
|
1.776e-05
|
|
|
CSH1
|
[NCBI]
|
1.7524e-05
|
|
|
SCNN1B
|
[NCBI]
|
1.7524e-05
|
|
|
FGB
|
[NCBI]
|
1.7524e-05
|
|
|
MTR
|
[NCBI]
|
1.74287e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
1.73284e-05
|
|
|
HCH
|
[NCBI]
|
1.73284e-05
|
|
|
C4A
|
[NCBI]
|
1.72422e-05
|
|
|
PFKM
|
[NCBI]
|
1.69079e-05
|
|
|
SURF1
|
[NCBI]
|
1.69079e-05
|
|
|
ADSL
|
[NCBI]
|
1.69079e-05
|
|
|
TCF3
|
[NCBI]
|
1.69079e-05
|
|
|
NETH
|
[NCBI]
|
1.68964e-05
|
|
|
hypouricemia, renal
|
[NCBI]
|
1.68964e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
1.68964e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
1.68964e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
1.68964e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
1.68964e-05
|
|
|
USH1D
|
[NCBI]
|
1.68964e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
1.68964e-05
|
|
|
ATLD
|
[NCBI]
|
1.68964e-05
|
|
|
CDB1
|
[NCBI]
|
1.68964e-05
|
|
|
PCS
|
[NCBI]
|
1.68964e-05
|
|
|
situs inversus viscerum
|
[NCBI]
|
1.68964e-05
|
|
|
kindler syndrome
|
[NCBI]
|
1.68964e-05
|
|
|
argininemia
|
[NCBI]
|
1.68964e-05
|
|
|
BRIC1
|
[NCBI]
|
1.68964e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
1.68964e-05
|
|
|
CTLN2
|
[NCBI]
|
1.68964e-05
|
|
|
PBT
|
[NCBI]
|
1.68964e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
1.68964e-05
|
|
|
glycogen storage disease ic
|
[NCBI]
|
1.68964e-05
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
1.68964e-05
|
|
|
CTSC
|
[NCBI]
|
1.66037e-05
|
|
|
SJS1
|
[NCBI]
|
1.65362e-05
|
|
|
TBS
|
[NCBI]
|
1.65362e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
1.65362e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.65362e-05
|
|
|
ALPS
|
[NCBI]
|
1.63423e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
1.63287e-05
|
|
|
NR4A2
|
[NCBI]
|
1.63287e-05
|
|
|
G6PT1
|
[NCBI]
|
1.63287e-05
|
|
|
PER2
|
[NCBI]
|
1.63287e-05
|
|
|
XRCC9
|
[NCBI]
|
1.63287e-05
|
|
|
HADHA
|
[NCBI]
|
1.63287e-05
|
|
|
TNFRSF13B
|
[NCBI]
|
1.63287e-05
|
|
|
GUCY2D
|
[NCBI]
|
1.63287e-05
|
|
|
FLT4
|
[NCBI]
|
1.63287e-05
|
|
|
FUT2
|
[NCBI]
|
1.63287e-05
|
|
|
PLG
|
[NCBI]
|
1.6007e-05
|
|
|
ADCYAP1
|
[NCBI]
|
1.59723e-05
|
|
|
GDNF
|
[NCBI]
|
1.58084e-05
|
|
|
CA2
|
[NCBI]
|
1.57826e-05
|
|
|
HAP1
|
[NCBI]
|
1.57826e-05
|
|
|
GALK1
|
[NCBI]
|
1.57826e-05
|
|
|
SFTPB
|
[NCBI]
|
1.57826e-05
|
|
|
CSF1
|
[NCBI]
|
1.57826e-05
|
|
|
FIH
|
[NCBI]
|
1.57787e-05
|
|
|
CLN3
|
[NCBI]
|
1.57787e-05
|
|
|
P2RX5
|
[NCBI]
|
1.56897e-05
|
|
|
RRM2B
|
[NCBI]
|
1.56897e-05
|
|
|
deleted in breast cancer 1
|
[NCBI]
|
1.56897e-05
|
|
|
SMAD6
|
[NCBI]
|
1.56897e-05
|
|
|
ALG9
|
[NCBI]
|
1.56897e-05
|
|
|
PHGDH
|
[NCBI]
|
1.56897e-05
|
|
|
MTIF2
|
[NCBI]
|
1.56897e-05
|
|
|
MMSDH
|
[NCBI]
|
1.56897e-05
|
|
|
SETD1A
|
[NCBI]
|
1.56897e-05
|
|
|
CHST5
|
[NCBI]
|
1.56897e-05
|
|
|
parathyroid hormone-responsive b1 gene
|
[NCBI]
|
1.56897e-05
|
|
|
MTL5
|
[NCBI]
|
1.56897e-05
|
|
|
actin-binding protein, 34-kd
|
[NCBI]
|
1.56897e-05
|
|
|
CC2D1A
|
[NCBI]
|
1.56897e-05
|
|
|
CAPN5
|
[NCBI]
|
1.56897e-05
|
|
|
E2F5
|
[NCBI]
|
1.56897e-05
|
|
|
TRRAP
|
[NCBI]
|
1.56897e-05
|
|
|
POMT2
|
[NCBI]
|
1.56897e-05
|
|
|
neurochondrin
|
[NCBI]
|
1.56897e-05
|
|
|
RCN1
|
[NCBI]
|
1.56897e-05
|
|
|
MTHFD1L
|
[NCBI]
|
1.56897e-05
|
|
|
KY
|
|